Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mallmann

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Der Internist|March 5, 2020
[Menopausal hormone therapy and breast cancer risk]P Mallmann, S Nitschmann
Methods and Findings in Experimental and Clinical Pharmacology|June 1, 1990
Investigations on cell-mediated immunity in patients with breast and ovarian carcinomas receiving a combination of chemotherapy and immunotherapy with thymopentinP Mallmann, D Krebs
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Response of the Uterus Commission of AGO to the Comment of M. Kolben, C. Dannecker and R. KürzlG Emons, P Mallmann,
Der Internist|June 15, 2010
[Adjuvant chemotherapy in older women with breast cancer. CALGB Study (The Cancer and Leukemia Group B Study)]P Mallmann, S Nitschmann
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1995
[Generation and activation of tumor-infiltrating lymphocytes (TIL) within the scope of lymphokine activated killer cell therapy (LAK-TIL therapy) in patients with advanced breast and ovarian carcinoma]P Mallmann, D Krebs
Archives of Gynecology and Obstetrics|January 1, 1992
Cell mediated immunity in infertilityP Mallmann, K Diedrich
Zentralblatt Fur Gynakologie|January 1, 1991
[The effect of adjuvant combined chemo/immunotherapy on immunological parameters and clinical course in patients with breast carcinoma]P Mallmann, D Krebs
American Journal of Obstetrics and Gynecology|October 1, 1990
Serum levels of interleukin-2 and tumor necrosis factor-alpha in women with recurrent abortionP Mallmann, A Werner, D Krebs
Methods and Findings in Experimental and Clinical Pharmacology|December 1, 1990
Effect of tamoxifen and high-dose medroxyprogesterone acetate (MPA) on cell-mediated immune functions in breast cancer patientsP Mallmann, K Dietrich, D Krebs
Immunitat Und Infektion|June 1, 1989
[Circadian rhythm of cellular and humoral immunologic parameters]P Mallmann, R Mallmann, R Nadstawek
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Der Internist|March 5, 2020
[Menopausal hormone therapy and breast cancer risk]P Mallmann, S Nitschmann
Methods and Findings in Experimental and Clinical Pharmacology|June 1, 1990
Investigations on cell-mediated immunity in patients with breast and ovarian carcinomas receiving a combination of chemotherapy and immunotherapy with thymopentinP Mallmann, D Krebs
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Response of the Uterus Commission of AGO to the Comment of M. Kolben, C. Dannecker and R. KürzlG Emons, P Mallmann,
Der Internist|June 15, 2010
[Adjuvant chemotherapy in older women with breast cancer. CALGB Study (The Cancer and Leukemia Group B Study)]P Mallmann, S Nitschmann
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1995
[Generation and activation of tumor-infiltrating lymphocytes (TIL) within the scope of lymphokine activated killer cell therapy (LAK-TIL therapy) in patients with advanced breast and ovarian carcinoma]P Mallmann, D Krebs
Archives of Gynecology and Obstetrics|January 1, 1992
Cell mediated immunity in infertilityP Mallmann, K Diedrich
Zentralblatt Fur Gynakologie|January 1, 1991
[The effect of adjuvant combined chemo/immunotherapy on immunological parameters and clinical course in patients with breast carcinoma]P Mallmann, D Krebs
American Journal of Obstetrics and Gynecology|October 1, 1990
Serum levels of interleukin-2 and tumor necrosis factor-alpha in women with recurrent abortionP Mallmann, A Werner, D Krebs
Methods and Findings in Experimental and Clinical Pharmacology|December 1, 1990
Effect of tamoxifen and high-dose medroxyprogesterone acetate (MPA) on cell-mediated immune functions in breast cancer patientsP Mallmann, K Dietrich, D Krebs
Immunitat Und Infektion|June 1, 1989
[Circadian rhythm of cellular and humoral immunologic parameters]P Mallmann, R Mallmann, R Nadstawek
Pageof 12